Drreddys Laboratories | Beneficio Operativo



Operating Profit Cambio Fecha
ANI Pharmaceuticals USD -4378000 16.14M 2024-12
Aurora Cannabis CAD 36.22M 38.61M 2024-12
Bayer EUR 3.53B 7.35B 2024-12
Canopy Growth CAD -23822000 21.8M 2024-12
Cipla INR 17.09B 952.7M 2024-12
Corcept Therapeutics USD 25.26M 21.34M 2024-12
Drreddys Laboratories INR 18.72B 1.17B 2024-12
GlaxoSmithKline GBP 696M 507M 2024-12
Hikma Pharmaceutical USD 327M 208M 2024-06
Lonza CHF 534M 194M 2024-06
Novartis USD 2.28B 1.34B 2024-12
Pacira USD 24.7M 164.23M 2024-12
Prestige Brands USD 91.96M 7.62M 2024-12
Richter Gedeon HUF 63.71B 2.25B 2024-09
Sun Pharmaceuticals INR 32.46B 606.8M 2024-12
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
Teva Pharmaceutical Industries USD 455M 506M 2024-12



Drreddys Laboratories Beneficio Operativo - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Apr 2025.